Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of the Tool " iPSC " (Induced Pluripotent Stem Cells) for the Functional Study of Mutations Responsible for Mental Retardation - Application to Familial Study of MYT1L Gene Mutations

NCT02980302 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT02980302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02980302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of the Tool " iPSC " (Induced Pluripotent Stem Cells) for the Functional Study of Mutations Responsible for Mental Retardation - Application to Familial Study of MYT1L Gene Mutations
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2015
Completion date
September 30, 2017
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asymptomatic carrier of the mutation of the gene myt1l, healthy volunteers, intellectual deficiency